3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
70
Neoplasms
7
Neoplasm Metastasis
5
Advanced Breast Cancer
5
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Neoplasms by Site
2
Breast Neoplasms, Male
2
Breast Diseases
2
Skin Diseases
1
Recurrence
1
Quality of Life
1
Low Grade Serous Ovarian Cancer
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Camurati-Engelmann Syndrome
1
Breast Neoplasm Female
1
Breast Cancer Metastatic
1
Breast Cancer Female
1
Bone Density
1
Anatomic Stage II Breast Cancer AJCC v8
1
Advanced Metastatic Breast Cancer
1
Interventions
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Advanced Metastatic Breast Cancer
×
Anastrozole
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA